| Wetzels JF
Renal outcomes in the ONTARGET study. [Comment, Letter]
Lancet 2008 Dec 13; 372(9655):2020; author reply 2020-1.
Full Citation | Publisher Full Text | Find Related Articles |
| New insights into missed endpoint trial. [News]
AIDS Patient Care STDS 2008 Nov; 22(11):917.
Full Citation | Publisher Full Text | Find Related Articles |
| Freedland SJ
PSA kinetics and surrogacy: ready for prime time? [Comment, Letter]
Lancet Oncol 2008 Nov; 9(11):1025-6.
Full Citation | Find Related Articles |
| Linz U
Aspects on the survival of patients with glioblastoma and the origin and histology of oligodendrogliomas. [Comment, Letter]
Nat Rev Cancer 2003 Jul; 3(7):doi:10.1038/nrc1121-c1.
Full Citation |
| Offner G, Toenshoff B, Höcker B, et al.
Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids. [Journal Article, Research Support, Non-U.S. Gov't]
Transplantation 2008 Nov 15; 86(9):1241-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Karlson EW, Shadick NA, Cook NR, et al.
Vitamin E in the primary prevention of rheumatoid arthritis: The women's health study. [Journal Article]
Arthritis Rheum 2008 Nov 15; 59(11):1589-95.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Wink K
[Instructions and methods for clinical trials of medicinal products for the treatment of chronic systolic heart failure] [English Abstract, Journal Article]
Arzneimittelforschung 2008; 58(9):475-9.
Abstract | Full Citation |
| Di Maio M, Daniele B, Gallo C, et al.
Re: Design and endpoints of clinical trials in hepatocellular carcinoma. [Comment, Letter]
J Natl Cancer Inst 2008 Nov 5; 100(21):1557; author reply 1557-8.
Full Citation | Publisher Full Text | Find Related Articles |
| Hollingshead MG
Antitumor efficacy testing in rodents. [Journal Article, Research Support, N.I.H., Extramural]
J Natl Cancer Inst 2008 Nov 5; 100(21):1500-10.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Schäfer S, Kolkhof P
Failure is an option: learning from unsuccessful proof-of-concept trials. [Journal Article]
Drug Discov Today 2008 Nov; 13(21-22):913-6.
Abstract | Full Citation | Find Related Articles |
  |
